Silexion Therapeutics Corp
SLXN
$3.78
$0.051.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -31.14M | 11.85M | -1.37M | -8.16M | |
| Total Depreciation and Amortization | -12.00K | 22.00K | 8.00K | 6.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 29.17M | -14.10M | -387.00K | 6.46M | |
| Change in Net Operating Assets | -947.00K | -430.00K | -- | 430.00K | |
| Cash from Operations | -2.93M | -2.65M | -1.75M | -1.26M | |
| Capital Expenditure | 0.00 | -16.00K | -6.00K | -4.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | 0.00 | |
| Cash from Investing | 0.00 | -16.00K | -6.00K | -4.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -250.00K | -- | -- | -- | |
| Issuance of Common Stock | 2.43M | 620.00K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 0.00 | 2.30M | -- | -- | |
| Cash from Financing | 2.18M | 2.92M | -- | 0.00 | |
| Foreign Exchange rate Adjustments | -11.00K | 25.00K | -56.00K | 94.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -753.00K | 276.00K | -1.81M | -1.17M | |